Xarelto is a new type of blood thinner approved in 2011 by the Food and Drug Administration and marketed in the U.S. by Johnson & Johnson’s subsidiary company, Janssen Pharmaceuticals.
When a person is taking blood thinners they must have routine blood tests and make adjustments to their dosage. They also must watch the foods they eat. This is part of Xarelto’s main selling point: it is a one-size-fits-all medication. Unfortunately, this characteristic is what also makes Xarelto dangerous.
Xarelto consumers have filed lawsuits alleging that the drug manufacturer failed to properly warn about some of the risks, including uncontrollable bleeding.
“[A] problem with the medication is it has what is called ‘a low therapeutic index.’ In other words, it can be safe at a certain point and dangerous within a very close range,” an attorney familiar with some of the Xarelto lawsuits said. “Someone can be 110 pounds or 200 pounds, old or young [and] with varying kidney functions and get the same dose and have a very different impact. Unlike the traditional blood thinner, Coumadin, where you have monitoring of the drug where the patient gets their blood checked periodically so the doctor can assess whether the levels are appropriate, you don’t do that with Xarelto.”
One of the most dangerous side effects of Xarelto is uncontrolled bleeding. Unlike other blood thinners, Xarelto has no antidote which makes stopping the bleeding difficult.
In one recent lawsuit, Nancy Packard filed a lawsuit against the makers of Xarelto for failing to warn about the lack of an antidote for the drug. She filed the lawsuit on behalf of her husband. Her husband took Xarelto for six months for atrial fibrillation and shortly after, he suffered bleeding in his brain. Doctors tried to save him by drilling a hole in his skull to alleviate building pressure but were unable to stop the bleeding, and he ultimately died.
In another recent lawsuit, Ruth McGowan filed a lawsuit on behalf of her deceased father, Thomas Dunkley. McGowan’s father took Xarelto to reduce the risk of stroke. However, he suffered serious bleeding in the brain after a taking the drug for a month. The lawsuit accuses the makers of Xarelto of not properly testing the drug and concealing safety risks.
There are currently 6,660 lawsuits pending in United States District Court of the Eastern District of Louisiana. Dr. Shezad Malik law firm is currently investigating Xarelto lawsuits from across the country. If you or a loved one was suffered from excessive or uncontrolled bleeding after taking Xarelto, contact our office immediately.